- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05528653
Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP" (e-PrEP)
January 3, 2024 updated by: Cindy Firnhaber, Vivent Health
To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)
Study Overview
Detailed Description
The goal of this study is to determine whether incorporating a telehealth model that allows for same-day appointments for PrEP delivery with the support of navigation leads to increased uptake and persistence of PrEP in young MSM/transgender of color and individuals in rural communities that have disproportionately not used PrEP.
The investigators will accomplish this by using an effectiveness-hybrid design that will allow us to both evaluate the interventions impact on relevant clinical outcomes as well as the effectiveness of the implementation strategy.
Our hypothesis is that by removing some of the barriers to care such as transportation, childcare, work schedule and potentially stigma with repeated clinic visits, the investigators will increase the uptake and persistence of PrEP amongst communities who historically have had many barriers to care and have not started PrEP.
Study Type
Interventional
Enrollment (Estimated)
150
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Billie Thomas
- Phone Number: 720-782-5003
- Email: billie.thomas@viventhealth.org
Study Contact Backup
- Name: Alexis Moore, MPH
- Phone Number: 303-393-8050
- Email: alexis.moore@viventhealth.org
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80245
- Active, not recruiting
- Vivent Health
-
-
Missouri
-
Saint Louis, Missouri, United States, 63103
- Recruiting
- Vivent Health
-
Contact:
- Leslie Cockerham, MD
- Email: leslie.cockerham@viventhealth.org
-
Contact:
- Sarah Chandler
- Email: sarah.chandler@Viventhealth.org
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53203
- Active, not recruiting
- Viventh Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 years and older
- No medical or mental health comorbidity that would preclude participating in a clinical study as deemed by the study investigator
- Able to understand and sign consent in English or with other language interpreter
- Able to stay in the state catchment area of the license health care provider
- No use of PrEP for more than 30 days in the last year
Exclusion Criteria:
- HIV positive
- If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) <30 mg/g
- <18 years of age
- No access to Internet or devise for telehealth
- Cis-gender Women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Open Label Descovy
Descovy for PrEP
|
HIV infection pre-exposure prophylaxis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
: To increase the number and proportion of individuals who start PrEP who have been under-represented in PrEP uptake including those who identify as Black and/or Latino MSM.
Time Frame: 18 months
|
Offer PrEP care via tele-health to reduce obstacles that clients have in coming to clinic.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To increase the number and proportion of individuals who are still taking PrEP and engaged in care at the end of 6 months by 30% and remain HIV negative including those who identify as Black and/or Latino MSM.
Time Frame: 18 months
|
Facilitate maintenance of care by offering Tele-health for initial and ongoing PrEP care to reduce social and structural barriers.
|
18 months
|
To assess the acceptability and implementation of the intervention by both patients and clinic staff.
Time Frame: 18 months
|
Obtain quantitative feedback via survey about services provided via Telehealth from patients and clinic staff.
|
18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Cindy Firnhaber, MD, Vivent Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 19, 2022
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
July 31, 2024
Study Registration Dates
First Submitted
May 19, 2022
First Submitted That Met QC Criteria
August 31, 2022
First Posted (Actual)
September 6, 2022
Study Record Updates
Last Update Posted (Actual)
January 5, 2024
Last Update Submitted That Met QC Criteria
January 3, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IN-US-412-6419
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Prevention
-
Prof Mags BeksinskaCompletedHIV Prevention | Pregnancy PreventionSouth Africa
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
International Partnership for Microbicides, Inc.CompletedHIV PreventionSouth Africa, Uganda
-
Microbicide Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompleted
-
Fenway Community HealthCompleted
-
University of California, Los AngelesUniversity of California, San Diego; California HIV/AIDS Research Program; Los... and other collaboratorsCompletedHIV PreventionUnited States
-
Microbicide Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedHIV PreventionUganda, South Africa, Zimbabwe
-
Massachusetts General HospitalMbarara University of Science and TechnologyCompleted
-
Orion Biotechnology Polska Sp. z o.o.Scope International AGCompleted
Clinical Trials on Descovy
-
HIV Prevention Trials NetworkGilead SciencesActive, not recruitingHIV PreventionUnited States, Brazil
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHuman Immunodeficiency VirusUnited States
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, United Kingdom, Canada, France, Italy, Puerto Rico, Belgium
-
CAN Community HealthRecruitingPre-Exposure Prophylaxis (PrEP) | Hiv PreventionUnited States
-
University of WashingtonUniversity of Colorado, Denver; Gilead Sciences; Kenya Medical Research InstituteCompleted
-
University of NebraskaCompletedHIV PreventionUnited States
-
University of MiamiActive, not recruiting
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...Institut d'Investigació Biomèdica de Bellvitge; Hospital Universitari de BellvitgeCompleted
-
University Health Network, TorontoGilead Sciences; University of Modena and Reggio Emilia; San Raffaele University... and other collaboratorsCompleted
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...Institut d'Investigació Biomèdica de Bellvitge; Hospital Universitari de BellvitgeCompleted